Loading...

APC anti-mouse CD3ε Antibody APC anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_APC_021606
C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) APC (filled histogram) or Armenian hamster IgG APC isotype control (open histogram).
  • 145-2C11_APC_021606
    C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) APC (filled histogram) or Armenian hamster IgG APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100311 25 µg NOK273
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100312 100 µg NOK867
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  2. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  3. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  4. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  5. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  6. Nelson J, et al. 2020. Sci Adv. 6:eaaz6893. PubMed
  7. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  8. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  9. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  10. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  11. Khayrullina G, et al. 2022. Glia. 70:1337. PubMed
  12. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  13. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  14. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  15. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  16. Agrafiotis A, et al. 2023. Acta Neuropathol. 145:335. PubMed
  17. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  18. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  19. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  20. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  21. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  22. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  23. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  24. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  25. Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed
  26. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  27. Fujimori S, et al. 2022. Elife. 11:. PubMed
  28. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  29. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  30. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  31. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  32. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  33. Okamoto M, et al. 2014. J Immunol. 192:2770. PubMed
  34. Nakamura M, et al. 2015. J Immunol. 194:243. PubMed
  35. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  36. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  37. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  38. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  39. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  40. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  41. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  42. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  43. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  44. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  45. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  46. Zhou H, et al. 2022. EMBO Rep. 23:e53475. PubMed
  47. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  48. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  49. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  50. Gao JL, et al. 2019. JCI Insight. 4:e132140. PubMed
  51. Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed
  52. Wang J, et al. 2018. Front Immunol. 9:371. PubMed
  53. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  54. Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed
  55. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  56. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  57. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  58. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  59. Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed
  60. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  61. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  62. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  63. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  64. Dong S, et al. 2021. Nature. 591:117. PubMed
  65. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  66. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  67. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  68. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  69. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  70. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  71. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  72. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  73. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  74. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  75. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  76. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  77. Oksenych V, et al. 2021. Biomolecules. 12:. PubMed
  78. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  79. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  80. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  81. Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed
  82. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  83. Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
  84. XS R, et al. 2015. Diabetes. 64 90. PubMed
  85. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  86. Ghandhi SA, et al. 2019. Sci Rep. 9:19434. PubMed
  87. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  88. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  89. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  90. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  91. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  92. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  93. Liu Y, et al. 2022. Am J Transl Res. 14:6856. PubMed
  94. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  95. Zhang Q, et al. 2022. JCI Insight. 7:. PubMed
  96. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  97. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  98. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  99. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  100. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  101. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  102. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  103. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  104. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  105. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  106. Castañeda–Zegarra S, et al. 2019. Biomolecules. 0.929166667. PubMed
  107. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  108. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  109. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  110. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  111. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  112. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  113. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  114. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  115. Koide S, et al. 2022. iScience. 25:103603. PubMed
  116. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  117. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  118. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  119. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  120. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  121. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  122. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  123. Sato Y, et al. 2022. Front Mol Biosci. 9:1040237. PubMed
  124. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  125. Stephens HM, et al. 2022. Methods Mol Biol. 2478:727. PubMed
  126. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  127. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  128. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  129. Arensman MD, et al. 2020. Oncoimmunology. 9:1800162. PubMed
  130. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  131. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  132. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  133. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  134. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  135. Cruz F, et al. 2016. Stem Cells Trans Med. 5: 488-499. PubMed
  136. Huang X, et al. 2021. Immunity. . PubMed
  137. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  138. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  139. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  140. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  141. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  142. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  143. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  144. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  145. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  146. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  147. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  148. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  149. Nelson J, et al. 2020. Sci Adv. 6:eaaz6893. PubMed
  150. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  151. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  152. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  153. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  154. Khayrullina G, et al. 2022. Glia. 70:1337. PubMed
  155. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  156. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  157. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  158. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  159. Agrafiotis A, et al. 2023. Acta Neuropathol. 145:335. PubMed
  160. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  161. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  162. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  163. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  164. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  165. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  166. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  167. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  168. Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed
  169. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  170. Fujimori S, et al. 2022. Elife. 11:. PubMed
  171. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  172. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  173. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  174. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  175. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  176. Okamoto M, et al. 2014. J Immunol. 192:2770. PubMed
  177. Nakamura M, et al. 2015. J Immunol. 194:243. PubMed
  178. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  179. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  180. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  181. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  182. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  183. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  184. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  185. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  186. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  187. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  188. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  189. Zhou H, et al. 2022. EMBO Rep. 23:e53475. PubMed
  190. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  191. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  192. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  193. Gao JL, et al. 2019. JCI Insight. 4:e132140. PubMed
  194. Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed
  195. Wang J, et al. 2018. Front Immunol. 9:371. PubMed
  196. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  197. Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed
  198. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  199. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  200. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  201. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  202. Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed
  203. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  204. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  205. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  206. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  207. Dong S, et al. 2021. Nature. 591:117. PubMed
  208. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  209. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  210. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  211. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  212. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  213. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  214. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  215. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  216. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  217. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  218. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  219. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  220. Oksenych V, et al. 2021. Biomolecules. 12:. PubMed
  221. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  222. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  223. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  224. Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed
  225. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  226. Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
  227. XS R, et al. 2015. Diabetes. 64 90. PubMed
  228. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  229. Ghandhi SA, et al. 2019. Sci Rep. 9:19434. PubMed
  230. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  231. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  232. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  233. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  234. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  235. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  236. Liu Y, et al. 2022. Am J Transl Res. 14:6856. PubMed
  237. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  238. Zhang Q, et al. 2022. JCI Insight. 7:. PubMed
  239. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  240. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  241. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  242. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  243. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  244. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  245. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  246. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  247. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  248. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  249. Castañeda–Zegarra S, et al. 2019. Biomolecules. 0.929166667. PubMed
  250. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  251. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  252. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  253. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  254. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  255. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  256. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  257. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  258. Koide S, et al. 2022. iScience. 25:103603. PubMed
  259. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  260. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  261. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  262. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  263. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  264. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  265. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  266. Sato Y, et al. 2022. Front Mol Biosci. 9:1040237. PubMed
  267. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  268. Stephens HM, et al. 2022. Methods Mol Biol. 2478:727. PubMed
  269. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  270. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  271. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  272. Arensman MD, et al. 2020. Oncoimmunology. 9:1800162. PubMed
  273. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  274. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  275. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  276. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  277. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  278. Cruz F, et al. 2016. Stem Cells Trans Med. 5: 488-499. PubMed
  279. Huang X, et al. 2021. Immunity. . PubMed
  280. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  281. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  282. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  283. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  284. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  285. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  286. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
RRID
AB_312676 (BioLegend Cat. No. 100311)
AB_312677 (BioLegend Cat. No. 100312)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_APC_021606
C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) APC (filled histogram) or Armenian hamster IgG APC isotype control (open histogram).
  • 145-2C11_APC_021606
    C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) APC (filled histogram) or Armenian hamster IgG APC isotype control (open histogram).
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
100311 25 µg NOK273
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100312 100 µg NOK867
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  2. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  3. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  4. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  5. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  6. Nelson J, et al. 2020. Sci Adv. 6:eaaz6893. PubMed
  7. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  8. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  9. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  10. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  11. Khayrullina G, et al. 2022. Glia. 70:1337. PubMed
  12. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  13. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  14. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  15. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  16. Agrafiotis A, et al. 2023. Acta Neuropathol. 145:335. PubMed
  17. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  18. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  19. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  20. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  21. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  22. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  23. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  24. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  25. Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed
  26. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  27. Fujimori S, et al. 2022. Elife. 11:. PubMed
  28. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  29. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  30. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  31. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  32. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  33. Okamoto M, et al. 2014. J Immunol. 192:2770. PubMed
  34. Nakamura M, et al. 2015. J Immunol. 194:243. PubMed
  35. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  36. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  37. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  38. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  39. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  40. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  41. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  42. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  43. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  44. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  45. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  46. Zhou H, et al. 2022. EMBO Rep. 23:e53475. PubMed
  47. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  48. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  49. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  50. Gao JL, et al. 2019. JCI Insight. 4:e132140. PubMed
  51. Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed
  52. Wang J, et al. 2018. Front Immunol. 9:371. PubMed
  53. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  54. Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed
  55. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  56. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  57. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  58. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  59. Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed
  60. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  61. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  62. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  63. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  64. Dong S, et al. 2021. Nature. 591:117. PubMed
  65. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  66. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  67. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  68. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  69. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  70. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  71. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  72. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  73. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  74. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  75. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  76. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  77. Oksenych V, et al. 2021. Biomolecules. 12:. PubMed
  78. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  79. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  80. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  81. Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed
  82. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  83. Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
  84. XS R, et al. 2015. Diabetes. 64 90. PubMed
  85. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  86. Ghandhi SA, et al. 2019. Sci Rep. 9:19434. PubMed
  87. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  88. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  89. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  90. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  91. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  92. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  93. Liu Y, et al. 2022. Am J Transl Res. 14:6856. PubMed
  94. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  95. Zhang Q, et al. 2022. JCI Insight. 7:. PubMed
  96. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  97. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  98. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  99. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  100. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  101. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  102. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  103. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  104. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  105. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  106. Castañeda–Zegarra S, et al. 2019. Biomolecules. 0.929166667. PubMed
  107. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  108. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  109. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  110. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  111. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  112. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  113. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  114. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  115. Koide S, et al. 2022. iScience. 25:103603. PubMed
  116. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  117. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  118. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  119. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  120. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  121. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  122. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  123. Sato Y, et al. 2022. Front Mol Biosci. 9:1040237. PubMed
  124. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  125. Stephens HM, et al. 2022. Methods Mol Biol. 2478:727. PubMed
  126. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  127. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  128. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  129. Arensman MD, et al. 2020. Oncoimmunology. 9:1800162. PubMed
  130. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  131. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  132. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  133. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  134. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  135. Cruz F, et al. 2016. Stem Cells Trans Med. 5: 488-499. PubMed
  136. Huang X, et al. 2021. Immunity. . PubMed
  137. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  138. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  139. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  140. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  141. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  142. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  143. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  144. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  145. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  146. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  147. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  148. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  149. Nelson J, et al. 2020. Sci Adv. 6:eaaz6893. PubMed
  150. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  151. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  152. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  153. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  154. Khayrullina G, et al. 2022. Glia. 70:1337. PubMed
  155. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  156. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  157. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  158. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  159. Agrafiotis A, et al. 2023. Acta Neuropathol. 145:335. PubMed
  160. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  161. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  162. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  163. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  164. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  165. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  166. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  167. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  168. Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed
  169. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  170. Fujimori S, et al. 2022. Elife. 11:. PubMed
  171. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  172. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  173. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  174. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  175. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  176. Okamoto M, et al. 2014. J Immunol. 192:2770. PubMed
  177. Nakamura M, et al. 2015. J Immunol. 194:243. PubMed
  178. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  179. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  180. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  181. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  182. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  183. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  184. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  185. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  186. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  187. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  188. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  189. Zhou H, et al. 2022. EMBO Rep. 23:e53475. PubMed
  190. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  191. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  192. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  193. Gao JL, et al. 2019. JCI Insight. 4:e132140. PubMed
  194. Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed
  195. Wang J, et al. 2018. Front Immunol. 9:371. PubMed
  196. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  197. Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed
  198. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  199. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  200. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  201. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  202. Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed
  203. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  204. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  205. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  206. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  207. Dong S, et al. 2021. Nature. 591:117. PubMed
  208. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  209. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  210. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  211. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  212. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  213. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  214. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  215. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  216. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  217. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  218. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  219. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  220. Oksenych V, et al. 2021. Biomolecules. 12:. PubMed
  221. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  222. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  223. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  224. Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed
  225. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  226. Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
  227. XS R, et al. 2015. Diabetes. 64 90. PubMed
  228. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  229. Ghandhi SA, et al. 2019. Sci Rep. 9:19434. PubMed
  230. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  231. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  232. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  233. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  234. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  235. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  236. Liu Y, et al. 2022. Am J Transl Res. 14:6856. PubMed
  237. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  238. Zhang Q, et al. 2022. JCI Insight. 7:. PubMed
  239. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  240. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  241. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  242. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  243. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  244. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  245. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  246. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  247. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  248. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  249. Castañeda–Zegarra S, et al. 2019. Biomolecules. 0.929166667. PubMed
  250. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  251. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  252. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  253. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  254. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  255. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  256. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  257. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  258. Koide S, et al. 2022. iScience. 25:103603. PubMed
  259. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  260. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  261. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  262. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  263. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  264. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  265. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  266. Sato Y, et al. 2022. Front Mol Biosci. 9:1040237. PubMed
  267. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  268. Stephens HM, et al. 2022. Methods Mol Biol. 2478:727. PubMed
  269. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  270. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  271. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  272. Arensman MD, et al. 2020. Oncoimmunology. 9:1800162. PubMed
  273. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  274. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  275. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  276. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  277. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  278. Cruz F, et al. 2016. Stem Cells Trans Med. 5: 488-499. PubMed
  279. Huang X, et al. 2021. Immunity. . PubMed
  280. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  281. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  282. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  283. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  284. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  285. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  286. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
RRID
AB_312676 (BioLegend Cat. No. 100311)
AB_312677 (BioLegend Cat. No. 100312)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account